Abstract
A chromogenic Limulus amebocyte lysate assay was used to measure the recovery of 1 endotoxin unit of endotoxin per ml. Purified human high-density lipoprotein, low-density lipoprotein, and apolipoprotein A1 (apo A1) at a maximum concentration of 1 g of protein per liter reduced the recovery to less than 40% of baseline in a both dose- and time-dependent manner and in the absence of other serum components. Furthermore, the lapine fever response to a dose of 1 ml of 5-ng/ml endotoxin per kg was reduced by greater than 0.5 degrees C (P less than 0.005) when the solution was preincubated in vitro with 0.5 g of apo A1 per liter. By the Limulus test, a maximum concentration of 0.01 g of apolipoprotein B (apo B) per liter (which contained deoxycholate, a known endotoxin-disaggregating agent) reduced recovery to 0% in a dose- but not time-dependent manner. In heat-inactivated (56 degrees C, 1 h) normal human serum, high-density lipoprotein cholesterol (P less than 0.005) and apo A1 (P less than 0.05) correlated inversely with endotoxin recovery, but, paradoxically, apo B correlated directly with endotoxin recovery (P less than 0.05), while low-density lipoprotein cholesterol showed no significant correlation. INTRALIPID alone had no effect on endotoxin recovery. Addition of a maximum of 10 g of INTRALIPID per liter to 0.0042 g of apo B per liter increased endotoxin recovery from approximately 30 to 80% (P less than 0.001), but addition of INTRALIPID to 0.25 g of apo A1 per liter decreased recovery from approximately 30 to 20% (P less than 0.001). We conclude that (i) lipoproteins are endotoxin inactivators; (ii) this ability of lipoproteins may be modulated by their lipid component (lipid-endotoxin interaction); (iii) apo A1 is capable of directly inactivating endotoxin (protein-endotoxin interaction).
MeSH Terms
Animals
Apolipoprotein A-I/pharmacology
Apolipoproteins B/pharmacology
Endotoxins/antagonists & inhibitors
Fat Emulsions, Intravenous/pharmacology
Humans
Lipoproteins/pharmacology
Lipoproteins, HDL/pharmacology
Lipoproteins, LDL/pharmacology
Rabbits
Chemicals
Apolipoprotein A-I
Apolipoproteins B
Endotoxins
Fat Emulsions, Intravenous
Lipoproteins
Lipoproteins, HDL
Lipoproteins, LDL
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Emancipator K
Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892.
Csako G
Elin R J
References (22)
22 references, click to expand
-
Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides.
J Clin Invest. 1982 Oct;70(4):877-88
PMID: 6749904
-
Correlation between endotoxin-neutralizing capacity of human plasma as tested by the limulus-amebocyte-lysate-test and plasma protein levels.
FEBS Lett. 1990 Dec 17;277(1-2):33-6
PMID: 1702736
-
Detection of endotoxin in triglyceride-rich lipoproteins in vitro.
J Lab Clin Med. 1991 Aug;118(2):186-93
PMID: 1856581
-
The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide.
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2704-8
PMID: 3517876
-
Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum.
J Infect Dis. 1986 Nov;154(5):784-91
PMID: 3095436
-
Control of lipopolysaccharide-high-density lipoprotein interactions by an acute-phase reactant in human serum.
Infect Immun. 1985 Oct;50(1):73-6
PMID: 2412965
-
Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins.
Infect Immun. 1989 Jul;57(7):2237-45
PMID: 2731990
-
Neutralization of bacterial lipopolysaccharides by human plasma.
J Clin Microbiol. 1985 Oct;22(4):590-5
PMID: 3908471
-
Effects of specific antibodies, hormones, and lipoproteins on bacterial lipopolysaccharides injected into the rat.
J Infect Dis. 1985 Jul;152(1):177-84
PMID: 4040145
-
Structure and function of lipopolysaccharide binding protein.
Science. 1990 Sep 21;249(4975):1429-31
PMID: 2402637
-
Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice.
J Clin Invest. 1990 Sep;86(3):696-702
PMID: 2394827
-
Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey.
J Clin Invest. 1981 Dec;68(6):1503-13
PMID: 7033286
-
Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins.
Infect Immun. 1981 Dec;34(3):835-43
PMID: 7037642
-
Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans.
J Infect Dis. 1981 Oct;144(4):329-36
PMID: 7026693
-
Limulus amebocyte lysate test for endotoxemia: investigations with a femtogram sensitive spectrophotometric assay.
Klin Wochenschr. 1981 Mar 2;59(5):213-8
PMID: 7012435
-
New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma.
J Clin Invest. 1981 Mar;67(3):827-37
PMID: 7204557
-
New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides.
J Clin Invest. 1979 Nov;64(5):1516-24
PMID: 227936
-
The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.
J Clin Invest. 1978 Dec;62(6):1313-24
PMID: 372234
-
Lack of specificity of the limulus lysate test in the diagnosis of pyogenic arthritis.
J Infect Dis. 1978 May;137(5):507-13
PMID: 659912
-
Factors affecting the sensitivity of Limulus lysate.
Appl Microbiol. 1974 Dec;28(6):1023-6
PMID: 4615633
-
An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation.
J Clin Invest. 1972 Jul;51(7):1790-7
PMID: 4624351
-
Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria.
N Engl J Med. 1970 Dec 10;283(24):1313-6
PMID: 5478453